Wednesday, September 16, 2026

Is Lee Jung-hoo’s Batting Streak Enough to Revive the Giants? Key Highlights from the MLB Game

Lee Jung-hoo (28, San Francisco Giants) recorded hits in two consecutive games after returning from a break.

Navigating U.S.-Korea Trade Relations: Key Insights on Tariff Negotiations and Investment Commitments

South Korea and the U.S. prepare for trade talks amid tariff threats, focusing on investment commitments and legislative timelines.

44 Billion Won Drug Smuggling Case: How a Telegram Network Operated Illegal Pharmaceutical Sales

A South Korean drug gang has been indicted for selling $33 million in illegal pharmaceuticals, using messaging apps for distribution.

Health

Celltrion Submits U.S. Phase 4 IND for High-Dose 240 mg Zymfentra

Celltrion has submitted a U.S. Phase 4 trial application to support the use of a higher 240 mg dose of Zymfentra, aiming to expand personalized dosing options and strengthen the drug's position in the U.S. market.

Blood Proteins May Offer Clues to Alzheimer’s Antibody Treatment Benefits and Side-Effect Risks

A South Korean study found that blood levels of complement proteins C1q and C3 may help predict amyloid reduction and ARIA risk in patients receiving lecanemab, though larger studies are needed.

Pentrym Confirms Combination Benefits With Existing Cancer Drugs, Targets “False Resistance”

Pentrym is testing whether targeting the tumor microenvironment alongside existing cancer drugs can overcome “false resistance” and improve treatment effectiveness.

YH42946: The Promising HER2 Targeted Oral Treatment Set to Transform Cancer Care in 2026

Yuhan Corporation will reveal early results of its oral HER2-targeted therapy candidate 'YH42946' in clinical trials by year-end.

SK Biopharm Achieves MSCI ESG AAA Rating for 3rd Consecutive Year: What It Means for the Pharma Industry

SK Biopharm has achieved the highest AAA rating in MSCI's ESG evaluation for three consecutive years.
Latest

MediPost Signs CDMO Agreement With Qstem for Dermal Papilla Cell Culture Medium

MediPost will establish a commercial-scale production system for Qstem’s hiPSC-based dermal papilla cell culture medium, expanding its CDMO business beyond cell therapies.

Celltrion Completes Integration of France’s Gifrer, Targets European Pharmacy Network

Celltrion has completed the post-acquisition integration of French health care company Gifrer and plans to use its pharmacy network as a hub for expanding direct sales across Europe.

JW Pharmaceutical Files for South Korea Phase 3 Trial of Once-Every-Two-Weeks Obesity Drug

JW Pharmaceutical is seeking to advance Bofanglutide into a South Korean Phase 3 trial, aiming to halve the dosing frequency of GLP-1 obesity treatments from once weekly to once every two weeks.

HLB Panagene Posts Operating Profit in First Half, Accelerates PNA Business Expansion

HLB Panagene remained profitable in the first half as it expands its PNA business and accelerates development of antibody-oligonucleotide conjugates.

Celltrion Publishes Population Pharmacokinetic Analysis of Vegzelma in International Journal

Celltrion has published integrated population pharmacokinetic analysis results for its Avastin biosimilar Vegzelma, confirming pharmacokinetic similarity with the reference drug.

“Preparing for the Next Pandemic After COVID-19”…South Korea Accelerates Development of Homegrown mRNA Vaccines

The South Korean government is accelerating domestic mRNA vaccine development to secure an independent vaccine technology platform capable of responding rapidly to future pandemics.

BMI2012: South Korea’s Next-Gen mRNA COVID-19 Vaccine Set for Clinical Trials

A consortium has received approval for the clinical trial of an mRNA-based COVID-19 variant vaccine, BMI2012.

Bonjo Capsule: A Game-Changer for Severe Myelofibrosis Patients – Here’s Why

The South Korean MFDS has approved a rare drug, Vonjo Capsule (Pacritinib Citrate), for treating myelofibrosis.

U.S. Military Resumes COVID-19 Inspections: What This Means for South Korea in 2026

The Korea Disease Control Agency and the U.S. military will resume quarantine operations for military and contracted aircraft post-COVID-19.

Revolutionary mRNA Discovery: How a Viral Strategy Tripled Stability and Boosted Protein Production

mRNA serves as a blueprint for protein production in cells but has a weakness: it degrades quickly once inside the cell.

Discover How GC WellBeing’s Laennec Transforms Pain Relief: A Game-Changer in Steroid Treatment!

GC WellBeing's study confirms pain relief effects of Laennec and its synergy with steroids, published in Scientific Reports.

Chung-Ang University Hospital Recruits Prostate Cancer Robotic Surgery Expert Choi Young-deuk, Who Holds Asia’s Highest Case Volume

Chung-Ang University Hospital has recruited Choi Young-deuk, a leading prostate cancer robotic surgeon with the highest number of prostate cancer robotic surgery cases in Asia, to strengthen its capabilities in complex and advanced urologic cancer treatment.

Celltrion’s Three ADC Drug Candidates All Receive FDA Fast Track Designation

Celltrion has secured U.S. FDA Fast Track designation for all three of its antibody-drug conjugate candidates, accelerating development of its emerging oncology drug pipeline.

“Last Hope Was Korea”…Korean Liver Transplant Team Saves Patient With Advanced Liver Cancer [K-Medical Report]

A Moroccan patient with advanced liver cancer and end-stage liver failure, deemed inoperable overseas, underwent a complex 17-hour two-donor living-donor liver transplant at Asan Medical Center and survived

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.